MRK Pulls Back After Earnings as Analyst Targets Hold Firm
Merck & Co. has given back some of its pre-earnings gains, slipping 2.9% on the week to $128.00 after Q2 results landed on August 4 — a muted post-print reaction that leaves the stock roughly $8 below where the most…